A hybridoma cell line and its secreted monoclonal antibody and its applications
By using monoclonal antibodies secreted by the hybridoma cell line AFB1SC and time-resolved fluorescent microsphere labeling technology, the sensitivity and accuracy issues of aflatoxin B1 detection have been resolved, achieving efficient quantitative analysis suitable for rapid on-site detection.
Patent Information
- Application Number
- CN202211575183.0
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2022-12-08
- Publication Date
- 2026-11-10
- Estimated Expiration
- 2042-12-08
AI Technical Summary
Existing methods for detecting aflatoxin B1 suffer from low sensitivity, insufficient accuracy, and are not suitable for rapid on-site detection and screening of large numbers of samples.
Monoclonal antibodies secreted by the hybridoma cell line AFB1SC were used, and time-resolved fluorescent microspheres were used to label the AFB1 monoclonal antibodies. Detection cards were prepared using time-resolved fluorescence immunochromatography for quantitative analysis.
It achieves highly sensitive, specific, and stable quantitative detection of aflatoxin B1, suitable for rapid on-site detection, with a detection limit of 0.133 μg/L, a linear range of 0.1–4 μg/L, and a shelf life of more than one year.
Smart Images

Figure BDA0003989137950000081 
Figure BDA0003989137950000082 
Figure BDA0003989137950000091
Abstract
Description
Technical Field
[0001] This invention relates to the field of biological detection technology, specifically to a hybridoma cell line and the monoclonal antibody it secretes, and its applications. Background Technology
[0002] Aflatoxin B1 (AFB1) is a secondary metabolite produced by Aspergillus flavus and Aspergillus parasiticus. It widely contaminates plant-based foods such as grains and nuts, as well as feed products such as soybean meal, wheat bran, and distillers' grains. It can occur at all stages of plant growth, harvest, and processing, and current agricultural and food processing technologies cannot completely remove the AFB1 that has been produced.
[0003] Animals and humans who ingest contaminated food may experience acute or chronic poisoning reactions such as diarrhea and fever. AFB1 can induce liver cancer by altering the activity of various enzymes and the concentration of certain components in plasma. It can also reduce the body's immunity and affect the body's normal oxidation processes. Long-term consumption of contaminated feed by animals can lead to a decrease in milk and egg production, damage to the vitality and DNA integrity of male animals, affecting the normal implantation of embryos into the uterus of female animals or causing abortion, seriously affecting animal production and reproductive performance. Furthermore, it poses a dual threat to human health through the consumption of tissues and dairy products.
[0004] Currently, the main methods for detecting AFB1 include instrumental analysis, enzyme-linked immunosorbent assay (ELISA), and colloidal gold immunochromatography. Instrumental analysis requires expensive equipment and professional operators, making it unsuitable for on-site testing and rapid screening of large numbers of samples. ELISA offers high throughput, but its operation is cumbersome, time-consuming, and the results are significantly affected by operator technique. Colloidal gold immunochromatographic test strips are simple to operate, have low production costs, and provide intuitive results, but their detection sensitivity is limited, offering only a qualitative "present" or "absent" result. Semi-quantitative analysis is also susceptible to factors such as batch composition of the colloidal gold solution and temperature, resulting in low accuracy.
[0005] Time-resolved fluorescence immunochromatography (RT-PCR) is a novel immunoassay technique that utilizes fluorescent microspheres coated with rare-earth ions as a fluorescent signal source to label monoclonal antibodies. These antibodies specifically react with antigens at a fixed region on a test strip, and the fluorescence signal is read by a fluorescence detector for quantitative analysis. This method offers higher sensitivity and accuracy, making it significant for rapid on-site detection and accurate screening of large numbers of samples. Therefore, developing a time-resolved fluorescence immunochromatography method with higher sensitivity and accurate quantitative detection of aflatoxin B1 is of great importance. Summary of the Invention
[0006] Based on this, one of the objectives of the present invention is to provide a hybridoma cell line AFB1SC, whose accession number is CCTCCNO:2022238.
[0007] This cell line was obtained by reacting AFB1 with CMO in DMF solution to obtain the hapten AFB1O, and then further conjugating the hapten with the carrier protein KLH to obtain the immunogen AFB1-DCC-KLH, followed by screening of mice. It can stably secrete monoclonal antibodies with high specificity for recognizing aflatoxin B1.
[0008] A second objective of this invention is to protect a monoclonal antibody secreted by the aforementioned hybridoma cell line.
[0009] The third objective of this invention is to protect the use of the above-mentioned hybridoma cell lines and monoclonal antibodies in the preparation of aflatoxin B1 detection reagents or kits.
[0010] The fourth objective of this invention is to protect a time-resolved fluorescence chromatography quantitative analysis kit for detecting aflatoxin B1. This kit includes at least a detection card, which comprises a PVC backing plate, a sample pad, a conjugate pad, a chromatography membrane, and an absorbent pad arranged sequentially from bottom to top along the width of the PVC backing plate, with adjacent components interconnected. An immunoprobe prepared from the aforementioned monoclonal antibody is immobilized on the conjugate pad. The chromatography membrane includes a T-detection line and a control line C arranged parallel to each other and spaced apart from the end near the sample pad to the end near the absorbent pad. The T-detection line is coated with AFB1 antigen, and the control line C is coated with goat anti-mouse IgG antibody.
[0011] Preferably, the preparation method of the immunoprobe on the pad is as follows: After the fluorescent microspheres are activated by the activating reagent, monoclonal antibody is added, the mixture is thoroughly mixed and reacted, then a blocking agent is added for blocking treatment, and the precipitate is centrifuged and resuspended to obtain the immunoprobe.
[0012] Preferably, the particle size of the fluorescent microspheres is 200–300 nm.
[0013] Preferably, the activating agent is N-hydroxysuccinimide and 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide.
[0014] Preferably, the resuspending solution used for resuspending the precipitate comprises an aqueous solution of pH 8.5 containing 0.01–0.03 mol / L Tris, 0.5–1.5% m / v BSA, 3–7% m / v sucrose, 0.01–0.03% m / v PEG-20000, 0.10–0.30% v / v Tween-20, and 0.03–0.07% m / v NaN3.
[0015] Preferably, the chromatography membrane is a cellulose acetate membrane, the binding pad is made of polyester fiber material, and the sample pad is made of glass fiber material.
[0016] The fifth objective of this invention is to protect the application of the above-mentioned reagent kit in the detection of grains and feeds, wherein the types of grains and feeds samples include, but are not limited to, corn, soybean meal, extruded soybeans, piglet compound feed, and sow concentrated feed.
[0017] This invention employs a rProtein A magnetic bead monoclonal antibody purification method, which is simple to operate, time-saving, and low-cost. The purity of the obtained monoclonal antibody can reach over 95%, effectively removing interference from impurity proteins and ensuring the accuracy of immunochromatographic results.
[0018] This invention employs time-resolved fluorescent microspheres to label AFB1 monoclonal antibodies. As a special type of functional microsphere, time-resolved fluorescent microspheres encapsulate thousands of high-brightness lanthanide fluorescent materials, significantly improving fluorescent labeling efficiency and analytical sensitivity. Simultaneously, the surface of the time-resolved fluorescent microspheres is modified with a suitable density of carboxyl groups, facilitating covalent bonding with proteins such as antibodies and improving the stability of the label. Compared to traditional fluorescent materials, time-resolved fluorescent microspheres exhibit a larger Stokes shift and a longer fluorescence lifetime. By appropriately extending the measurement time and allowing the fluorescence in the sample to decay before measuring the fluorescent signal of the label, various fluorescent background interferences in the sample matrix can be effectively eliminated, improving detection accuracy and achieving higher sensitivity. Time-resolved fluorescence immunochromatography retains the advantages of immunochromatography—simplicity, speed, and on-site detection—while time-resolved fluorescent microspheres provide high sensitivity, exhibiting characteristics such as high sensitivity, strong specificity, good stability, and high accuracy, enabling quantitative analysis.
[0019] The time-resolved fluorescence chromatography quantitative analysis kit provided by this invention uses a monoclonal antibody secreted by the hybridoma cell line AFB1SC, which has high specificity for AFB1. It can detect the content of AFB1 with high sensitivity and high specificity. Its linear range is 0.1-4 μg / L, and the detection limit is 0.133 μg / L. The recovery rate in corn samples is 89.74-98.40%, and the recovery rate in piglet compound feed samples is 92.69-94.95%. The detection sensitivity is much lower than other kits for detecting AFB1 on the market, and the shelf life can reach more than 1 year. Attached Figure Description
[0020] Figure 1 The appearance of the reagent kit prepared according to this invention;
[0021] Figure 2 This is a schematic diagram of the test strip structure prepared according to the present invention;
[0022] Figure 3 This is a standard curve diagram of AFB1 detection in Embodiment 2 of the present invention;
[0023] Figure 4This is a comparison chart of the detection of corn samples using the present invention and the ELISA kit in Example 3;
[0024] Figure 5 This is a comparison chart of the detection of piglet compound feed samples using the present invention and the ELISA kit in Example 3.
[0025] In the picture:
[0026] 1. PVC backing plate, 2. Sample pad, 3. Binding pad, 4. Chromatography membrane, 5. Absorbent pad. Detailed Implementation
[0027] The present invention will now be described in further detail with reference to specific embodiments, so that those skilled in the art can more clearly understand the present invention.
[0028] The following embodiments are for illustrative purposes only and are not intended to limit the scope of the invention. All other embodiments obtained by those skilled in the art based on the specific embodiments of the invention without inventive effort are within the protection scope of the invention.
[0029] In the embodiments of the present invention, unless otherwise specified, all raw material components are commercially available products well known to those skilled in the art; in the embodiments of the present invention, unless specifically specified, the technical means used are conventional means well known to those skilled in the art.
[0030] Example 1
[0031] (1) Obtaining the hybridoma cell line AFB1SC
[0032] 2 mg of AFB1 was dissolved in DMF (formyldimethylamine) solution, 5 mg of Na2CO3 and 25 mg of CMO (carboxymethyl hydroxylamine hemihydrochloride) were added and mixed well. The mixture was stirred at room temperature for 12 h, then evaporated to dryness under N2. 2 mL of 0.05 mol / L hydrochloric acid was added to dissolve the hapten AFB1O, and then 2 mL of ethyl acetate was added to extract the hapten AFB1O. AFB1O was completely dissolved in DMF, 5 mg of NHS (N-hydroxysuccinimide ester) and 10 mg of DCC (1,3-dicyclohexylcarbodiimide) were added, and the mixture was activated at room temperature for 12 h to obtain solution A. 2 mL of carrier protein KLH was dissolved in PBS solution to obtain solution B. Solution A was slowly added to solution B, and the mixture was reacted in an ice bath for 12 h. After the reaction was completed, the mixture was dialyzed against PBS solution at 4 °C for 72 h to obtain the AFB1-DCC-KLH immunogen. Using the same procedure, DCC and KLH were replaced by EDC [1-ethyl-(3-dimethylaminopropyl)carbodiimide] and BSA (bovine serum albumin), respectively, to prepare AFB1-EDC-BSA coated antigen.
[0033] Immunogen AFB1-DCC-KLH was diluted to 500 μL with physiological saline and emulsified with an equal volume of Freund's adjuvant to obtain a homogeneous suspension. The immunogen emulsion was subcutaneously injected into different locations on the back of Balb / c mice (purchased from Wuhan Center for Disease Control and Prevention, Hubei Province, China). The first injection used complete Freund's adjuvant, and the second injection used incomplete Freund's adjuvant. Blood was collected from the mice, and serum titers were determined by ic-ELISA. Mice showing the best specificity to AFB1 were selected for cell fusion. Spleen cells from immunized mice were fused with Sp2 / 0 myeloma cells at a ratio of 10:1 to 5:1 to obtain hybridoma cells. Hybridoma cells showing a positive reaction were cloned by limiting dilution. Cell colonies with high antibody titers, good morphology, and monocolony growth were selected for further subcloning. When the cell subcloning positivity rate was 100% for two consecutive times, the hybridoma cells were expanded and cryopreserved.
[0034] The hybridoma cell line was named AFB1SC and was deposited at the China Center for Type Culture Collection on July 18, 2022, with accession number CCTCC NO:2022238.
[0035] (2) Purification of AFB1 monoclonal antibody
[0036] Hybridoma cells in the logarithmic growth phase were collected and counted, and the cell count was adjusted to 1×10⁻⁶. 6The ascites fluid was induced in mice by intraperitoneal injection of [number] particles / mL. The ascites fluid was collected after significant abdominal distension. The mouse ascites fluid was filtered through a 0.45 μm filter membrane. The filtrate was collected and centrifuged at 10000 rpm for 8–10 min at 4 °C. The supernatant was transferred to a centrifuge tube. 1 mL of rProtein A magnetic beads was placed on a magnetic rack and magnetically separated until the supernatant was clear. The liquid was discarded, and 5 mL of PBS solution was added and mixed. The mixture was then magnetically separated until the supernatant was clear, and the liquid was discarded. This process was repeated twice. 1 mL of mouse ascites fluid was added, and the mixture was inverted and mixed for 30 min. Magnetic separation was then performed until the supernatant was clear, and the liquid was discarded. 5 mL of [other solution] was added... Vortex the PBS solution, magnetically separate until the supernatant is clear, and mix 50 μL of the liquid with 80 μL of Coomassie Brilliant Blue solution. Observe the color of the solution and repeat this step until the solution is colorless. Add 4 mL of elution buffer (0.1 mol / L glycine aqueous solution, pH 3.0), vortex for 30 s, magnetically separate until the supernatant is clear, and mix 50 μL of the liquid with 80 μL of Coomassie Brilliant Blue solution. Observe the color of the solution and repeat this step until the blue solution is colorless. Collect the remaining eluent in a centrifuge tube. This eluted component is the monoclonal antibody. Quickly adjust the pH of the solution to 7.0–8.0 with neutralization buffer (1 mol / L Tris-HCl aqueous solution, pH 8.5). Add the eluent to an ultrafiltration centrifuge tube, centrifuge at 4000 rpm for 20 min at 4 °C, collect the antibody solution in the ultrafiltration centrifuge tube, and dialyze. Change the dialysate every 6–8 hours for a total of 2 days. Store the dialyzed monoclonal antibody at 4 °C for later use. After use, wash the magnetic beads 2-3 times with PBS solution, add 4 times the volume of 20% ethanol solution, and store at 4°C.
[0037] (3) Preparation of time-resolved fluorescent immunoprobes
[0038] Take 50 μL of 10 mg / mL fluorescent microsphere stock solution (purchased from Huizhi Biotechnology, particle size 200 nm), add 450 μL of pH 6.0 MES (4-morpholinoethanesulfonic acid) buffer to dilute to a final concentration of 1 mg / mL, centrifuge at 12000 rpm, 4 °C for 15 min, resuspend the precipitate in MES buffer to the original volume, repeat the operation twice, sonicate the microsphere solution for 10 s, add 1 mg / mL NHS (N-hydroxysuccinimide) aqueous solution and 1 mg / mL EDC [1-(3-dimethylaminopropyl)-3-ethylcarbodiimide] aqueous solution in equal proportions to the microsphere solution, vortex to mix, and activate at room temperature in the dark for 20 min; after activation, centrifuge at 12000 rpm, 4 °C for 15 min, and resuspend the precipitate in pH 6.0 buffer. Resuspend the microspheres in 8.0% borate buffer to the original volume. Repeat the above operation twice. Wash the microspheres to remove excess activator. Sonicate the microsphere solution for 20 seconds. Add 50 μg of AFB1 monoclonal antibody and incubate at room temperature in the dark for 3 hours. Add 50 μL of 10% BSA solution, vortex to mix, and incubate at room temperature in the dark for 3 hours. After the reaction, centrifuge at 12000 rpm and 4°C for 10 minutes. Resuspend the microspheres in the reconstitution solution (containing an aqueous solution of pH 8.5 0.02 mol / L Tris, 1% m / V BSA, 5% m / V sucrose, 0.02% m / V PEG-20000, 0.15% V / V Tween-20, and 0.05% m / V NaN3) to the original volume to obtain the time-resolved fluorescent immunofluorescence probe. Store at 4°C for later use.
[0039] (4) Preparation of time-resolved fluorescence immunochromatographic test strips
[0040] Preparation of the conjugate pad: The time-resolved fluorescent immunoprobe solution was uniformly dispersed on the conjugate pad using a gold sprayer at a spray rate of 2.5 μL / cm, and dried at 37–50 °C.
[0041] Assembly of the test strip: Glue the nitrocellulose membrane to the middle of the PVC base plate, glue the conjugation pad and sample pad to the left end of the nitrocellulose membrane in sequence, and glue the absorbent pad to the right side of the nitrocellulose membrane. There is a 2-3 mm overlap between each adjacent structure.
[0042] Stretching: AFB1-BSA antigen (i.e., the AFB1-EDC-BSA coated antigen prepared in Example 1) and goat anti-mouse IgG antibody (purchased from Wuhan Feiyi Co., Ltd.) were diluted to concentrations of 0.3 mg / mL and 0.3 mg / mL respectively with coating solution (PBS solution of 1% m / v sucrose). AFB1-BSA antigen and goat anti-mouse IgG antibody were immobilized on nitrocellulose membranes with a spray rate of 0.8 μL / cm using a membrane stretcher to form the detection line T and the control line C. The membranes were dried in an oven at 37-50℃ for 12 hours, cut into strips, and the test strips were inserted into the cartridge to form a test card.
[0043] Detection: Under constant temperature of 37℃, 100μL of the test solution is added to the sample tank, and after incubation for 6 minutes, it is tested by the instrument.
[0044] In this embodiment, the cellulose acetate membrane is model PALL170 (purchased from Shanghai Jieyi Biotechnology Co., Ltd.), the conjugate pad is made of polyester fiber material, and the sample pad is model MA0120 (purchased from Shanghai Jieyi Biotechnology Co., Ltd.).
[0045] Example 2
[0046] (1) Linear range of AFB1 detection
[0047] Prepare AFB1 standard solutions and use this kit for detection. Detect each concentration five times. After the reaction, use a fluorescence reader to read the fluorescence intensity of the C-line and T-line, and the T / C value, and calculate B / B0. Plot a standard curve with the logarithm of the AFB1 standard solution concentrations on the x-axis and the corresponding B / B0 values on the y-axis. The results are shown below. Figure 3 The linear regression equation for AFB1 detection is: y = -0.5158x + 0.4279, with a correlation coefficient R0. 2 =0.9932, with a linear range of 0.1 to 4 μg / L.
[0048] (2) Detection line for AFB1 detection
[0049] Following the method for establishing a standard curve, the T / C values of 20 blank standard solutions were determined, and the corresponding concentration values were calculated by substituting them into the standard curve. The average (C) and standard deviation (SD) of the 20 measured concentration values were then obtained. According to the formula C + 3SD, the detection limit of this kit for AFB1 was calculated to be 0.133 μg / L.
[0050] (3) Specificity of AFB1 detection
[0051] The standard solutions of AFB1 analogs AFB2 (purchased from Bailingwei Technology Co., Ltd.), AFG1 (purchased from Bailingwei Technology Co., Ltd.), and AFG2 (purchased from Bailingwei Technology Co., Ltd.) were determined, and their concentrations were calculated using a standard curve. The cross-reactivity rate (%) was calculated as the detected concentration divided by the actual concentration. The results are shown in Table 1. The calculations showed that this kit had almost no cross-reactivity with AFB2, AFG1, and AFG2, indicating good specificity.
[0052] Table 1. Specificity of AFB1 detection
[0053]
[0054] (4) Precision of AFB1 detection
[0055] AFB1 standard solutions at low, medium, and high concentrations were tested five times for each concentration, for a total of three batches. The results are shown in Table 2. The intra-batch coefficient of variation for AFB1 detection was 3.70–8.03% (<10%), and the inter-batch coefficient of variation was 7.28–12.21% (<15%), indicating that the kit has good precision.
[0056] Table 2 Precision of AFB1 Detection
[0057]
[0058]
[0059] (5) Recovery rate of AFB1 detection
[0060] Blank corn samples and piglet compound feed samples were pulverized and sieved. 1 ± 0.01 g of each sample was accurately weighed into centrifuge tubes, and AFB1 standard was added at concentrations of 10, 20, and 40 μg / kg. 4 mL of 60% v / v methanol aqueous solution was accurately added, and the mixture was vortexed and shaken thoroughly at 2000 rpm for 5 min, followed by centrifugation at 4000 rpm for 3 min. 200 μL of the supernatant was collected, and 800 μL of PBS solution was added and vortexed. Finally, 100 μL of the mixture was used for detection with this kit. The measured concentration was calculated using a standard curve. The recovery rate was calculated using the formula: Recovery rate (%) = Measured concentration / Added concentration × 100%. The results are shown in Table 3. The recovery rate of AFB1 in corn samples was 89.74–98.40%, and the recovery rate in piglet compound feed samples was 92.69–94.95%.
[0061] Table 3. Recovery rate of AFB1 detection
[0062]
[0063]
[0064] Example 3
[0065] Add 50 μL of the AFB1 standard solution from the kit to each well of a 96-well plate, performing two parallel wells for each concentration. Then, add 50 μL of enzyme-labeled antigen solution to each well and mix well. Incubate at 37°C for 20 min, wash with washing buffer, and spin dry. Repeat 5 times. Next, add 50 μL each of substrate solution and chromogenic solution to each well and mix well. Incubate at 37°C for 15 min. Finally, add 50 μL of stop solution to each well and mix well. Measure the OD within 5 min. 450nm The standard curve was plotted with the logarithm of the concentration of the standard solution on the x-axis and B / B0 on the y-axis.
[0066] An appropriate amount of AFB1 standard solution was added to blank corn and piglet compound feed. The samples were then tested using an ELISA kit (purchased from Biosen Food Safety Technology Co., Ltd.) and this kit, respectively, and correlation curves were plotted. The results in the corn sample test are as follows: Figure 4 Correlation coefficient R 2 =0.9983; the result in the test of piglet compound feed samples is as follows. Figure 5 Correlation coefficient R 2 =0.9867, which indicates that the detection results of this kit are consistent with those of commercial ELISA kits.
[0067] Example 4: Stability Study of the Reagent Kit
[0068] This kit was subjected to an accelerated stability test at 50°C for 60 days. The kit was then tested on days 1, 3, 7, 15, 30, and 60. The kit maintained normal detection performance throughout the test and has a shelf life of more than one year.
[0069] In summary, this invention can rapidly and quantitatively detect the AFB1 content in a sample. It is simple to operate, highly specific, sensitive, and reproducible, and has good application prospects.
[0070] The present invention provides a time-resolved fluorescence immunochromatographic quantitative analysis kit for detecting AFB1. The kit consists of: a package containing a test card, the test card containing an assembled test strip and a card shell, the package containing a desiccant; a reagent cartridge containing a buffer solution, the buffer solution being PBS solution; and an ID card with a built-in standard curve.
[0071] It should be noted that the above embodiments are only for further elaboration and explanation of the technical solution of the present invention, and are not intended to further limit the technical solution of the present invention. The method of the present invention is only a preferred embodiment and is not intended to limit the scope of protection of the present invention. Any modifications, equivalent substitutions, improvements, etc., made within the spirit and principles of the present invention should be included within the scope of protection of the present invention.
Claims
1. A hybridoma cell line AFB1SC, with accession number CCTCC NO:2022238.
2. A monoclonal antibody, characterized in that, The monoclonal antibody is secreted by the hybridoma cell line described in claim 1.
3. The use of the hybridoma cell line AFB1SC according to claim 1 or the monoclonal antibody according to claim 2 in the preparation of aflatoxin B1 detection reagents or kits.
4. A time-resolved fluorescence chromatography quantitative analysis kit for detecting aflatoxin B1, characterized in that, It includes at least a test card, which includes a PVC back plate, a sample pad, a binding pad, a chromatography membrane, and an absorbent pad arranged sequentially from bottom to top along the width direction of the PVC back plate, and adjacent components are connected to each other; The binding pad is immobilized with an immune probe prepared from the monoclonal antibody of claim 2. The chromatography membrane includes a T detection line and a control line C arranged in parallel and spaced apart from the sample pad end to the absorbent pad end. The T detection line is coated with AFB1 antigen, and the control line C is coated with goat anti-mouse IgG antibody.
5. The time-resolved fluorescence chromatography quantitative analysis kit for detecting aflatoxin B1 according to claim 4, characterized in that, The preparation method of the immunoprobe on the conjugate pad is as follows: After activating the fluorescent microspheres with an activating reagent, add monoclonal antibody, mix thoroughly, react, add blocking agent for blocking, centrifuge and resuspend the precipitate to obtain the product.
6. The time-resolved fluorescence chromatography quantitative analysis kit for detecting aflatoxin B1 according to claim 5, characterized in that, The fluorescent microspheres have a particle size of 200~300nm.
7. The time-resolved fluorescence chromatography quantitative analysis kit for detecting aflatoxin B1 according to claim 5 or 6, characterized in that, The activating agents are N-hydroxysuccinimide and 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide.
8. The time-resolved fluorescence chromatography quantitative analysis kit for detecting aflatoxin B1 according to claim 5, characterized in that, The resuspending solutions used for resuspending the precipitate consist of an aqueous solution of 0.01–0.03 mol / L Tris at pH 8.5, 0.5–1.5% m / v BSA, 3–7% m / v sucrose, 0.01–0.03% m / v PEG-20000, 0.10–0.30% v / v Tween-20, and 0.03–0.07% m / v NaN3.
9. The time-resolved fluorescence chromatography quantitative analysis kit for detecting aflatoxin B1 according to claim 5, characterized in that, The chromatography membrane is a cellulose acetate membrane, the binding pad is made of polyester fiber, and the sample pad is made of glass fiber.
10. The use of the time-resolved fluorescence chromatography quantitative analysis kit for detecting aflatoxin B1 as described in any one of claims 4 to 9 in the detection of aflatoxin B1 in grains or feed.
